Synaffix Expands Partnership Horizon with Boehringer Ingelheim
January 9, 2025 - 17:10
In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
MORE NEWS
December 3, 2025 - 18:33
New Technology Hub Launched to Enhance Defense and Intelligence CapabilitiesGeneral Dynamics Information Technology has inaugurated a new Mission Emerge Center in Springfield, Virginia, aimed at fostering collaboration with the Defense Department, the Intelligence...
December 3, 2025 - 05:19
Breakthrough in Quantum Technology: Entangling Light and Electrons at Room TemperatureA groundbreaking development in quantum technology has emerged with the creation of a compact device capable of entangling light and electrons without the need for super-cooling. This innovation...
December 2, 2025 - 08:54
The Rise of Technology Bans in K-12 Schools: A Call for Change at UMichK-12 school-wide cell phone and student-owned technology bans have become an increasingly prevalent trend in the post-pandemic era. As educational institutions adapt to the challenges posed by the...
December 1, 2025 - 22:05
Investors Respond to Jacobs Solutions' Major Project Wins in Infrastructure and Quantum TechnologyIn the past week, Jacobs Solutions celebrated multiple significant project victories that have captured the attention of investors. The company has been appointed as the Project Independent...